| Authors: |
Schiavone A; Vaccines and Diagnostics Department, Moredun Research Institute, Penicuik, United Kingdom., Edwards JC; The Pirbright Institute, Woking, United Kingdom., Vigneswaran E; The Pirbright Institute, Woking, United Kingdom., De Brito RCF; The Pirbright Institute, Woking, United Kingdom., Hothi H; aVaxziPen, Abingdon, United Kingdom., Frossard JP; Animal and Plant Health Agency, Addlestone, United Kingdom., Beechener ES; Scotland's Rural College, SRUC, Edinburgh, United Kingdom., Calvert JG; Zoetis Inc., Kalamazoo, MI, USA., Burkard CT; The Roslin Institute and The Royal (Dick) School of Veterinary Studies, University of Edinburgh, Midlothian, United Kingdom., Balasch M; Zoetis Manufacturing & Research Spain S.L., Girona, Spain., Seaton AV; Vaccines and Diagnostics Department, Moredun Research Institute, Penicuik, United Kingdom., Stevens M; The Roslin Institute and The Royal (Dick) School of Veterinary Studies, University of Edinburgh, Midlothian, United Kingdom., Howard MK; aVaxziPen, Abingdon, United Kingdom., Graham SP; The Pirbright Institute, Woking, United Kingdom. Electronic address: simon.graham@pirbright.ac.uk., Opriessnig T; Vaccines and Diagnostics Department, Moredun Research Institute, Penicuik, United Kingdom; Department of Veterinary Diagnostic and Production Animal Medicine, Iowa State University, Ames, IA, USA. Electronic address: tanjaopr@iastate.edu. |
